[1] |
陈剑,胡庆雷,孙彦春,等.脑胶质瘤术后超选介入化疗联合系统化疗的临床研究[J].介入放射学杂志,2010,19(10):817-820.
|
[2] |
毛德强,潘玲,戴勤弼,等.脑胶质瘤术后放疗联合同步超选动脉化疗的近期疗效观察[J].重庆医科大学学报,2011,36(6):759-761.
|
[3] |
刘许昌,王健.老年恶性脑胶质瘤术后替莫唑胺化疗联合放疗的近远期疗效[J].中国老年学杂志,2015,35(20):5835-5836.
|
[4] |
傅浩,万林林,杨灵,等.放疗联合口服替莫唑胺治疗恶性脑胶质瘤术后患者的临床疗效研究[J].中国全科医学,2011,14(14):1556-1558.
|
[5] |
宋杰,付廷刚,徐蒙,等.儿童脑胶质瘤术后多足球囊32P残腔内放疗同步替莫唑胺化疗临床观察[J].山东医药,2015,55(3):64-66.
|
[6] |
翟小明,王建平,张军宁,等.成人脑恶性胶质瘤术后两种同步放化疗方案的疗效比较[J].南方医科大学学报,2012,32(2):255-257.
|
[7] |
陈伟,齐珺,王茂德,等.高分级脑胶质瘤术后同步放化疗联合辅助化疗与单纯放疗治疗的疗效对比[J].中国实用神经疾病杂志,2016,19(20):37-39.
|
[8] |
常世川,范仕兵,李刚,等.高级别脑胶质瘤术后同步放化疗的疗效观察[J].现代肿瘤医学,2013,21(1):52-54.
|
[9] |
Effat LK,El-Harouni AA,Amr KS,et al.Screening of dystrophin gene deletions in Egyptian patientswith DMD/BMD muscular dystrophies[J].Dis Markers,2013,16(3-4):125-129.
|
[10] |
Roest PA,Bout M,van der Tuijn AC,et al.Splicing mutations in DMD/BMD detected by RT-PCR/PTT:detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD[J].JMed Genet,2016,33(11):935-939.
|
[11] |
Gümüs P,ztürk V,Bozkurt E,et al.Evaluation of the gingival inflammation in pregnancy and postpartum via 25-hydroxy-vitamin D3,prostaglandin E2and TNF-alpha levels in saliva[J].Arch Oral Biol,2016,63(3):1-6.
|
[12] |
Cimbek A,Gürsoy G,Kirnap NG,et al.Relation of obesity with serum 25 hydroxy vitamin D3levels in type 2 diabetic patients[J].JRes Med Sci,2012,17(12):1119-1123.
|
[13] |
Sibilska IK,Sicinski RR,Ochalek JT,et al.Synthesis and biological activity of 25-hydroxy-2-methylene-vitamin D3analoguesmonohydroxylated in the a-ring[J].JMed Chem,2014,57(20):8319-8331.
|
[14] |
Orcel P.Advances treatmentof osteoporosis:newmolecules,new strategies[J].Bull Acad Natl Med,2010,194(8):1505-1516.
|
[15] |
Jagtap VR,Ganu JV,Nagane NS.BMD and serum intact osteocalcin in postmenopausal osteoporosis women[J].Indian JClin Biochem,2011,26(1):70-73.
|